摘要:
To provide a heterologous protein expression system which enables the fission yeast Schizosaccharomyces pombe as a host to produce of a heterologous protein which is almost impossible to express, or if possible, produced at low levels, under control of conventional promoters.The present invention provides an expression for use in the fission yeast Schizosaccharomyces pombe, a transformant carrying the expression vector, a method for producing a heterologous protein using the transformant, in particular a method for producing a heterologous protein in which a heat shock protein gene promoter in Schizosaccharomyces pombe is used to regulate gene expression by application of a specific form of stress, whereby the timing of the production of the desired heterologous protein can be controlled.
摘要:
The present invention provides a peptide partially comprising an amino acid sequence of FGF-5 or FGF-5S (i.e., the alternatively spliced form of FGF-5), the peptide being capable of controlling physiological function(s) of FGF-5. A pharmaceutical composition containing the peptide of the invention as an active component may regulate the physiological function(s) of FGF-5 such as regulation of development or growth of a head or body hair, regulation of nutrition or function of a cranial nerve system, regulation of platelets, and/or promotion or inhibition of proliferation or differentiation of a vascular endothelial cell.
摘要:
The present invention provides: genetically modified yeasts such as mutant yeasts having an ability to produce N-linked sugar chains of Man5GlcNAc2 and a decreased ability to produce O-linked sugar chains, mutant yeasts having an ability to produce N-linked sugar chains of Man5GlcNAc2 and further having an ability to produce N-linked sugar chains of GlcNAc1Man5GlcNAc2, and mutant yeasts having an increased ability to produce and secrete proteins and an ability to produce N-linked sugar chains of Man5GlcNAc2; and a method for producing glycoproteins using them.
摘要:
The present invention provides: genetically modified yeasts such as mutant yeasts having an ability to produce N-linked sugar chains of Man5GlcNAc2 and a decreased ability to produce O-linked sugar chains, mutant yeasts having an ability to produce N-linked sugar chains of Man5GlcNAc2 and further having an ability to produce N-linked sugar chains of GlcNAc1Man5GlcNAc2, and mutant yeasts having an increased ability to produce and secrete proteins and an ability to produce N-linked sugar chains of Man5GlcNAc2; and a method for producing glycoproteins using them.